External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

NANOS 2026

We will be contributing to topics related to
-
11:00 AM
Duration 60mins Boston, USA
Clinical Practice Guidelines for Managing Thyroid Eye Disease: A Systematic Review
Seth G, Wagner L, Ko S, Idowu O, Jehangir N, Otu-Adum A, Crowell M, Parise H, Lin W
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 60mins Boston, USA
Assessing the Burden of Thyroid Eye Disease in US Patients: A Survey- Based Study
Tamhankar M, Lelli G, Ko S, Idowu O, Jezhangir N, Hill S, Moor H, Oluboyede Y, Lin W
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
02:00 PM
Duration 12mins Boston, USA
Primary Results of the Phase 3 SatraGO-1 and SatraGO-2 Trials: Efficacy and Safety of Satralizumab▼ in Thyroid Eye Disease
Subramanian P, Briceño C, Idowu O, Brockwell L, Ruf T, Kuenzel T, Brittain C, Barteselli G, Ortiz-Perez S
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Coming soon